Exploring the therapeutic mechanisms of proinflammatory myelin-laden macrophages retention in the injured spinal lesion core
探索损伤脊髓病变核心中促炎髓磷脂巨噬细胞保留的治疗机制
基本信息
- 批准号:10569068
- 负责人:
- 金额:$ 37.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAdhesionsAdhesivesAffectApoptoticAreaBone MarrowCellsChemotactic FactorsChronicChronic PhaseCollagenDataDemyelinating DiseasesDepositionEmigrationsEndothelial CellsExtracellular MatrixFibronectinsGenerationsGoalsHumanImmuneIn SituInfiltrationInflammationInflammation MediatorsInflammatoryInjuryInvestigationKnowledge acquisitionLesionLipidsMacrophageMediatingMyelinNecrosisNerve RegenerationOutcomePathway interactionsPhagocytesPhasePhenotypeProcessPublic HealthPublicationsRecovery of FunctionRegulationReportingResearchResolutionSignal TransductionSiteSpinalSpinal Cord LesionsSpinal InjuriesSpinal cord injuryTailTestingTherapeuticTherapeutic InterventionTissuesTractionUnited States National Institutes of HealthVascular Endothelial CellVertebral columnWorkautocrineaxon growthdensitydisabilityhealingimprovedinjuredinnovationmigrationnerve stem cellneuralneural growthneuroinflammationnew therapeutic targetnovelnovel strategiesnovel therapeutic interventionpreventremyelinationtissue regenerationtreatment strategyuptakevascular inflammation
项目摘要
PROJECT SUMMARY
Spinal cord injury (SCI) progression can be divided into acute and chronic phases. Following the primary injury,
bone marrow-derived macrophages (BMDMɸ) infiltrate to the injured epicenter where they engulf myelin debris
to become proinflammatory myelin-laden macrophages (Mye-Mϕ). Mye-Mɸ accumulate in the injured core
densely and occupy almost entire epicenter of injured area indefinitely, which would consequently result in: 1)
They prevent the entry and growth of axons, which inhibits remyelination. 2) They lose their normal phagocytic
capacity for dead cells and cellular debris, which may exacerbate the inflammatory microenvironment. 3) They
release inflammatory mediators, which trigger an inflammatory cascade that prevents tissue regeneration. Our
data indicated that the migratory potential of BMDMɸ is directly suppressed when they engulf myelin debris. We
resently reported that newly formed microvessels and their lining endothelial cells (ECs) in the injured cord are
able to engulf myelin debris. Myelin debris engulfment by ECs (Mye-ECs) significantly increased deposition of
extracellular matrices (ECM) such as collagen and fibronectin which may serve as extrinsic factor to promote
the adhesive interaction between Mye-Mϕ-ECs and lead to Mye-Mϕ retention in the injured lesion. Our central
hypothesis is that Mye-Mϕ retention in the injured core is mediated by intrinsic and extrinsic mechanisms which
promote Mye-Mɸ retention through ECM adhesion. The objective of the proposed project is to investigate the
underlying mechanisms of Mye-Mϕ sequestration and identify treatment strategies that target Mye-Mɸ in the
injury site, which may restore normal Mφ functions and lead to improvements in lesion resolution. The rationale
for the proposed research is based on preliminary investigations that demonstrate Mye-Mɸ become ‘trapped’ via
a mix of intrinsic (Mɸ produced) and extrinsic (environmental) mechanisms within the lesion. Our central
hypothesis will be tested in the following specific aims: 1) To study whether myelin debris, either directly or via
autocrine pathways, inhibits BMDMϕ migration ability which promotes their lesion retention; 2) To determine
whether adhesive ECM produced by Mye-ECs in the injured core aggravates Mye-Mɸ retention; and 3) To
investigate whether targeting Mye-Mφ and subsequently switching their phenotype toward a reparative
phenotype promotes tissue healing. This research is innovative because we propose that inflammatory Mye-
Mɸ trapped within the injured spinal cord lesion contribute to the chronic SCI lesion, preventing full resolution of
the injury. This work is significant because Aims 1 and 2 will identify the underlying mechanisms governing
Mye-Mφ retention, while Aim 3 will demonstrate novel strategies for the resolution of chronic SCI inflammation
and lesions. This will have the positive impact of identifying novel therapeutic strategies for therapeutic
interventions not only to treat SCI but also to other demyelinating disorders that generate myelin debris.
项目摘要
脊髓损伤(SCI)的进展可分为急性期和慢性期。在原发伤之后,
骨髓源性巨噬细胞(BMDM)浸润到损伤中心,在那里它们吞噬髓鞘碎片
成为促炎性的充满髓鞘的巨噬细胞(Mye-M)。Mye-M在受损的核心中积聚
密集,几乎无限期地占据整个受伤区域的震中,这将导致:1)
它们阻止轴突的进入和生长,从而抑制髓鞘再生。2)它们失去了正常的吞噬细胞
死亡细胞和细胞碎片的能力,这可能会加剧炎症微环境。3)他们
释放炎症介质,引发炎症级联反应,阻止组织再生。我们
数据表明,当BMDM β吞噬髓磷脂碎片时,它们的迁移潜力被直接抑制。我们
近年来有报道称,损伤脊髓中新生的微血管及其衬里内皮细胞(EC),
能够吞噬髓磷脂碎片内皮细胞(Mye-ECs)对髓鞘碎片的吞噬显著增加了内皮细胞的沉积,
细胞外基质(ECM),如胶原蛋白和纤连蛋白,其可以作为促进细胞增殖的外源性因子。
Mye-M-ECs之间的粘附作用导致Mye-M-ECs在损伤的病变中滞留。我们的中央
假设Mye-M蛋白在受损核心中的滞留是由内在和外在机制介导的,
通过ECM粘附促进Mye-M细胞保留。拟议项目的目的是调查
Mye-M囊膜隔离的潜在机制,并确定靶向Mye-M囊膜的治疗策略,
损伤部位,这可能会恢复正常的Mφ功能,并导致病变解决的改善。的理由
这项研究是基于初步调查,证明Mye-M通过
病变内的内在(M β产生)和外在(环境)机制的混合。我们的中央
将在以下具体目标中检验这一假设:1)研究髓鞘碎片是否直接或通过
自分泌途径,抑制BMDM细胞迁移能力,促进其病变保留; 2)确定
由Mye-EC在受损核心中产生的粘附性ECM是否破坏Mye-EC的保留;以及3)
研究是否靶向Mye-Mφ并随后将其表型转换为修复性
表型促进组织愈合。这项研究是创新的,因为我们提出,炎症性Mye-
被困在受伤的脊髓损伤内的脊髓损伤有助于慢性SCI损伤,阻止了脊髓损伤的完全消退。
伤口这项工作意义重大,因为目标1和目标2将确定管理
Mye-Mφ保留,而Aim 3将展示解决慢性SCI炎症的新策略
和损伤。这将对确定新的治疗策略产生积极的影响,
这些干预不仅用于治疗SCI,而且用于产生髓鞘碎片的其他脱髓鞘疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yi Ren其他文献
Yi Ren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yi Ren', 18)}}的其他基金
Emerging role of exosomes derived from peripheral immune cells in regulation of neuroinflammation in response to neural injury
外周免疫细胞衍生的外泌体在调节神经损伤反应中的神经炎症中的新作用
- 批准号:
10450269 - 财政年份:2022
- 资助金额:
$ 37.89万 - 项目类别:
Emerging role of exosomes derived from peripheral immune cells in regulation of neuroinflammation in response to neural injury
外周免疫细胞衍生的外泌体在调节神经损伤反应中的神经炎症中的新作用
- 批准号:
10579325 - 财政年份:2022
- 资助金额:
$ 37.89万 - 项目类别:
Exploring the therapeutic mechanisms of proinflammatory myelin-laden macrophages retention in the injured spinal lesion core
探索损伤脊髓病变核心中促炎髓磷脂巨噬细胞保留的治疗机制
- 批准号:
10419193 - 财政年份:2022
- 资助金额:
$ 37.89万 - 项目类别:
Mechanisms and Regulation of Nuclear mRNA Export
核 mRNA 输出的机制和调控
- 批准号:
10201667 - 财政年份:2019
- 资助金额:
$ 37.89万 - 项目类别:
Mechanisms and Regulation of Nuclear mRNA Export
核 mRNA 输出的机制和调控
- 批准号:
10441264 - 财政年份:2019
- 资助金额:
$ 37.89万 - 项目类别:
Mechanisms and Regulation of Nuclear mRNA Export
核 mRNA 输出的机制和调控
- 批准号:
10686213 - 财政年份:2019
- 资助金额:
$ 37.89万 - 项目类别:
Mechanisms and Regulation of Nuclear mRNA Export
核 mRNA 输出的机制和调控
- 批准号:
10118556 - 财政年份:2019
- 资助金额:
$ 37.89万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 37.89万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 37.89万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 37.89万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 37.89万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 37.89万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 37.89万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 37.89万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 37.89万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 37.89万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 37.89万 - 项目类别:
Operating Grants














{{item.name}}会员




